Israel China Biotechnology (ICB) Ltd (ICB) — Net Asset Quality Index
Israel China Biotechnology (ICB) Ltd (ICB) has a Net Asset Quality Index of 38.3% as of June 2021. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA6.66 Million minus total liabilities of ILA4.11 Million yields net assets of ILA2.55 Million. A higher index indicates a stronger, lower-leverage balance sheet. See defensive interval ratio of Israel China Biotechnology (ICB) Ltd to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Israel China Biotechnology (ICB) Ltd Net Asset Quality Index Over Time (2015–2020)
This chart shows how Israel China Biotechnology (ICB) Ltd's Net Asset Quality Index has evolved across 6 annual periods from 2015 to 2020. As of June 2021, the index stands at 38.3%, representing net assets of ILA2.55 Million against total assets of ILA6.66 Million ILA. Explore ICB operating cash flow to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Israel China Biotechnology (ICB) Ltd (2015–2020)
The table below presents the year-by-year Net Asset Quality Index for Israel China Biotechnology (ICB) Ltd from 2015 to 2020, covering 6 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see ICB stock market capitalisation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2020 | 5.6% | ILA470.00K | ILA8.34 Million | ILA7.87 Million | ▼ -10.7 pp |
| 2019 | 16.3% | ILA1.89 Million | ILA11.57 Million | ILA9.68 Million | ▼ -58.7 pp |
| 2018 | 75.1% | ILA7.41 Million | ILA9.88 Million | ILA2.46 Million | ▲ +217.9 pp |
| 2017 | -142.8% | ILA-1.69 Million | ILA1.18 Million | ILA2.87 Million | ▼ -189.8 pp |
| 2016 | 47.0% | ILA1.91 Million | ILA4.06 Million | ILA2.15 Million | ▼ -23.8 pp |
| 2015 | 70.7% | ILA5.78 Million | ILA8.18 Million | ILA2.39 Million | — |